Related references
Note: Only part of the references are listed.Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation
Juan Carlos Hernandez-Boluda et al.
LEUKEMIA (2021)
Upfront transplantation may have better outcomes than pretransplant cytoreductive therapy for treating patients with MDS-EB-1 or MDS-EB-2
Yili Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Emerging agents and regimens for AML
Hongtao Liu
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Molecular pathogenesis of the myeloproliferative neoplasms
Graeme Greenfield et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Decoding Bone Marrow Fibrosis in Myelodysplastic Syndromes
Megan Melody et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data
Sijian Yu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Patients of Myelodysplastic Syndrome with Mild/Moderate Myelofibrosis and a Monosomal Karyotype are Independently Associated with an Adverse Prognosis: Long-Term Follow-Up Data
Na Wang et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study
Immacolata Tartaglione et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)
Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial
Li Xuan et al.
LANCET ONCOLOGY (2020)
Novel therapeutics in myeloproliferative neoplasms
Sangeetha Venugopal et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Gene mutational analysis by NGS and its clinical significance in patients with myelodysplastic syndrome and acute myeloid leukemia
Jifeng Yu et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)
Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous Leukemia
Thomas Schroeder et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
MDS overlap disorders and diagnostic boundaries
Tiffany N. Tanaka et al.
BLOOD (2019)
Analysis of clinical and molecular features of MDS patients with complex karyotype in China
Yanling Ren et al.
BLOOD CELLS MOLECULES AND DISEASES (2019)
Challenges in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)
Brianna N. Smith et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose
Stefanie Jilg et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2019)
Targeted therapies for myeloproliferative neoplasms
Bing Li et al.
BIOMARKER RESEARCH (2019)
Myelodysplastic syndromes current treatment algorithm 2018
David P. Steensma
BLOOD CANCER JOURNAL (2018)
The epidemiology and clinical characteristics of myeloproliferative neoplasms in Malaysia
Yee Yee Yap et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2018)
Myelodysplastic Syndromes, Version 2.2017 Clinical Practice Guidelines in Oncology
Peter L. Greenberg et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies
Abdallah Abou Zahr et al.
HAEMATOLOGICA (2016)
Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies
Abdallah Abou Zahr et al.
HAEMATOLOGICA (2016)
Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems
Bin Fu et al.
MODERN PATHOLOGY (2014)
Minimizing risk of hypomethylating agent failure in patients with higher-risk MDS and practical management recommendations
Valeria Santini et al.
LEUKEMIA RESEARCH (2014)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
Guideline for the diagnosis and management of myelofibrosis
John T. Reilly et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge
Julie Schanz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis
Nicolaus Kroeger et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome
Guoqing Wei et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2011)
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Nicolaus Kroeger et al.
BLOOD (2009)
Clinical Relevance of Bone Marrow Fibrosis and CD34-Positive Cell Clusters in Primary Myelodysplastic Syndromes
Matteo Giovanni Della Porta et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes
G. Buesche et al.
LEUKEMIA (2008)
Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or acute myeloid leukemia with multilineage dysplasia
Bart L. Scott et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
The burden of fatigue and quality of life in myeloproliferative disorders (MPDs) - An international internet-based survey of 1179 MPD patients
Ruben A. Mesa et al.
CANCER (2007)
Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia
Bruce D. Cheson et al.
BLOOD (2006)
Myelofibrosis in primary myelodysplastic syndromes - Clinical and biological significance
D Marisavljevic et al.
MEDICAL ONCOLOGY (2004)
Allogeneic hematopoietic stem cell transplantation for myelofibrosis
HJ Deeg et al.
BLOOD (2003)
Share Paper
